Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Trichomonas vaginalis causes the most prevalent sexually transmitted infection worldwide. Trichomonads have been detected in prostatic tissues from prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Chronic prostatic inflammation is known as a risk factor for prostate enlargement, benign prostatic hyperplasia symptoms, and acute urinary retention. Our aim was to investigate whether T. vaginalis could induce inflammatory responses in cells of a benign prostatic hyperplasia epithelial cell line (BPH-1). When BPH-1 cells were infected with T. vaginalis, the protein and mRNA of inflammatory cytokines, such as CXCL8, CCL2, IL-1β, and IL-6, were increased. The activities of TLR4, ROS, MAPK, JAK2/STAT3, and NF-κB were also increased, whereas inhibitors of ROS, MAPK, PI3K, NF-κB, and anti-TLR4 antibody decreased the production of the 4 cytokines although the extent of inhibition differed. However, a JAK2 inhibitor inhibited only IL-6 production. Culture supernatants of the BPH-1 cells that had been incubated with live T. vaginalis (trichomonad-conditioned medium, TCM) contained the 4 cytokines and induced the migration of human monocytes (THP-1 cells) and mast cells (HMC-1 cells). TCM conditioned by BPH-1 cells pretreated with NF-κB inhibitor showed decreased levels of cytokines and induced less migration. Therefore, it is suggested that these cytokines are involved in migration of inflammatory cells. These results suggest that T. vaginalis infection of BPH patients may cause inflammation, which may induce lower urinary tract symptoms (LUTS).
Abstract
Trichomonas vaginalis causes the most prevalent sexually transmitted infection worldwide. Trichomonads have been detected in prostatic tissues from prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Chronic prostatic inflammation is known as a risk factor for prostate enlargement, benign prostatic hyperplasia symptoms, and acute urinary retention. Our aim was to investigate whether T. vaginalis could induce inflammatory responses in cells of a benign prostatic hyperplasia epithelial cell line (BPH-1). When BPH-1 cells were infected with T. vaginalis, the protein and mRNA of inflammatory cytokines, such as CXCL8, CCL2, IL-1β, and IL-6, were increased. The activities of TLR4, ROS, MAPK, JAK2/STAT3, and NF-κB were also increased, whereas inhibitors of ROS, MAPK, PI3K, NF-κB, and anti-TLR4 antibody decreased the production of the 4 cytokines although the extent of inhibition differed. However, a JAK2 inhibitor inhibited only IL-6 production. Culture supernatants of the BPH-1 cells that had been incubated with live T. vaginalis (trichomonad-conditioned medium, TCM) contained the 4 cytokines and induced the migration of human monocytes (THP-1 cells) and mast cells (HMC-1 cells). TCM conditioned by BPH-1 cells pretreated with NF-κB inhibitor showed decreased levels of cytokines and induced less migration. Therefore, it is suggested that these cytokines are involved in migration of inflammatory cells. These results suggest that T. vaginalis infection of BPH patients may cause inflammation, which may induce lower urinary tract symptoms (LUTS).
참고문헌 (42)
- World Health Organization, "Global incidence and prevalence of selected curable sexually transmitted infections - 2008" (2008), WHO
- Hobbs MM, "Modern diagnosis of Trichomonas vaginalis infection", Sex Transm Infect, 89, pp.434~438 (2013)
- Krieger JN, "Trichomoniasis in men: old issues and new data", Sex Transm Dis, 22, pp.83~96 (1995)
- Quinlivan EB, "Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care", Sex Transm Dis, 39, pp.671~677 (2012)
- Jong Jin Lee, "PCR for Diagnosis of Male Trichomonas vaginalis Infection with Chronic Prostatitis and Urethritis", The Korean Journal of Parasitology, 50(2), pp.157~159 (2012), 대한기생충학ㆍ열대의학회[DOI]
- Mitteregger D, "High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue", Med Microbiol Immunol, 201, pp.113~116 (2012)
- Sena AC, "Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention", Clin Infect Dis, 44, pp.13~22 (2007)
- Seo MY, "Inflammatory response of prostate epithelial cells to stimulation by Trichomonas vaginalis", Prostate, 74, pp.441~449 (2014)
- Garraway WM, "High prevalence of benign prostatic hypertrophy in the community", Lancet, 338, pp.469~471 (1991)
- Robert G, "Should we investigate prostatic inflammation for the management of benign prostatic hyperplasia?", Eur Urol Suppl, 8, pp.879~886 (2009)
- Wei JT, "Urologic diseases in America project: benign prostatic hyperplasia", J Urol, 173, pp.1256~1261 (2005)
- Wang X, "Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation", J Biol Chem, 287, pp.18376~18385 (2012)
- Theyer G, "Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia", Lab Invest, 66, pp.96~107 (1992)
- Fujita K, "Monocyte chemotactic protein-1(MCP-1", CCL2)is associated with prostatic growth dysregulation and benign prostatic hyperplasia, 2010, pp.70, 473~481
- Nickel JC, "Asymptomatic inflammation and", or infection in benign prostatic hyperplasia, 1999, pp.84, 976~981
- Bedalov G, "Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study", Acta Med Croatica, 48, pp.105~109 (1994)
- Moodley P, "Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus", Clin Infec Dis, 34, pp.519~522 (2002)
- Han IH, "Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells", Parasite Immunol, 34, pp.8~14 (2012)
- Abbas AK, "Cellular and molecular immunology", pp.76~78 (2012), Elsevier Saunders
- Desireddi NV, "Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome", J Urol, 179, pp.1857~1861 (2008)
- Mazzucchelli L, "Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma", Am J Pathol, 149, pp.501~509 (1996)
- Kramer G, "Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?", Eur Urol, 51, pp.1202~1216 (2007)
- Schmitz N, "Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection", J Virol, 79, pp.6441~6448 (2005)
- Abbott DW, "The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO", Curr Biol, 14, pp.2217~2227 (2004)
- Na-Yeong Gu, "Trichomonas vaginalis induces IL-1β production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux", The Prostate, 76(10), pp.885~896 (2016), Wiley-Blackwell[DOI]
- Kashyap M, "Inflammasomes are important mediators of prostatic inflammation associated with BPH", J Inflamm, 12 (2015)[DOI]
- Castro P, "Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia", Prostate, 60, pp.153~159 (2004)
- Liu L, "Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia", Urology, 74, pp.340~344 (2009)
- Heinrich P, "Interleukin-6 and the acute phase response", Biochem J, 265, pp.621~636 (1990)
- Greenhill CJ, "IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3", J Immunol, 186, pp.1199~1208 (2011)
- Kramer G, "Could inflammation be a key component in the progression of benign prostatic hyperplasia?", Curr Opin Urol, 16, pp.25~29 (2006)
- Bouraoui Y, "Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer", Cancer Detect Prev, 32, pp.23~32 (2008)
- Adler HL, "Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma", J Urol, 161, pp.182~187 (1999)
- Daniel J. George, "The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480", Clin Cancer Res, 11, pp.1815~1820 (2005)
- Ernst M, "Acquiring signalling specificity from the cytokine receptor gp130", Trends Genet, 20, pp.23~32 (2004)
- Li L, "The emerging role of the PI3-K-Akt pathway in prostate cancer progression", Prostate Cancer Prostatic Dis, 8, pp.108~118 (2005)
- Heinrich PC, "Principles of interleukin(IL)-6-type cytokine signalling and its regulation", Biochem J, 374, pp.1~20 (2003)
- Forman HJ, "Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling", Am J Respir Crit Care Med, 166, pp.S4~S8 (2002)
- Min A, "NOX2-derived ROS-mediated surface translocation of BLT1 is essential for exocytosis in human eosinophils induced by LTB4", Int Arch Allergy Immunol, 165, pp.40~51 (2014)
- Makni-Maalej K, "Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1", 2 and p38 MAPkinase, 2013, pp.85, 92~100
- Min YD, "Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line", Inflamm Res, 56, pp.210~215 (2007)
- Son Y, "Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?", J Signal Transduct, 2011 (2011)[DOI]